Allogene Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.04

-0.05 (-4.59%)

As of Nov 7, 2:07 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +2,016.3% upside

Low Target $17.29

Average Target $22.01

High Target $30.07

Current Price $1.04

Current
$1.04

Target
$22.01

$17.29 $22.01 avg $30.07

Scenario Analysis

Bear Case

$17.29

1,562.5%

Low target

Base Case

$22.01

+2,016.3%

Avg target

Bull Case

$30.07

+2,791.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.46

-76.7% from high

52-Week Low

$1.04

+0.0% from low

Target vs 52W High

$22.01

+393.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%